US2335616A - Steroidal hormone intermediates and their preparation - Google Patents
Steroidal hormone intermediates and their preparation Download PDFInfo
- Publication number
- US2335616A US2335616A US418076A US41807641A US2335616A US 2335616 A US2335616 A US 2335616A US 418076 A US418076 A US 418076A US 41807641 A US41807641 A US 41807641A US 2335616 A US2335616 A US 2335616A
- Authority
- US
- United States
- Prior art keywords
- oxime
- steroid
- mixture
- acid
- rearrangement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000543 intermediate Substances 0.000 title description 7
- 230000003637 steroidlike Effects 0.000 title description 6
- 229940088597 hormone Drugs 0.000 title description 4
- 239000005556 hormone Substances 0.000 title description 4
- 238000002360 preparation method Methods 0.000 title description 4
- 238000000034 method Methods 0.000 description 33
- 150000002923 oximes Chemical class 0.000 description 24
- 239000002253 acid Substances 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- 150000003431 steroids Chemical class 0.000 description 19
- 239000000203 mixture Substances 0.000 description 17
- 150000003512 tertiary amines Chemical class 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 238000006237 Beckmann rearrangement reaction Methods 0.000 description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- 230000008707 rearrangement Effects 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 11
- -1 androstane compound Chemical class 0.000 description 11
- 230000003301 hydrolyzing effect Effects 0.000 description 10
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 150000004820 halides Chemical class 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- RRUDCFGSUDOHDG-UHFFFAOYSA-N acetohydroxamic acid Chemical compound CC(O)=NO RRUDCFGSUDOHDG-UHFFFAOYSA-N 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 238000006146 oximation reaction Methods 0.000 description 5
- 150000003128 pregnanes Chemical class 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 150000001441 androstanes Chemical class 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000000844 transformation Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- FMGSKLZLMKYGDP-UHFFFAOYSA-N Dehydroepiandrosterone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 FMGSKLZLMKYGDP-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- QZLYKIGBANMMBK-UGCZWRCOSA-N androstane group Chemical group [C@@H]12CCC[C@@]1(C)CC[C@H]1[C@H]2CC[C@H]2CCCC[C@]12C QZLYKIGBANMMBK-UGCZWRCOSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 2
- 229960002847 prasterone Drugs 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 description 1
- YJDYCULVYZDESB-HKQXQEGQSA-N (5r,8r,9s,10s,13s,14s)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one Chemical class C1CCC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 YJDYCULVYZDESB-HKQXQEGQSA-N 0.000 description 1
- GMVAAADTMXYSDE-XFNFOBRPSA-N 2-[(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethenol Chemical compound OC=C[C@H]1CC[C@H]2[C@@H]3CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C GMVAAADTMXYSDE-XFNFOBRPSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- JXRGUPLJCCDGKG-UHFFFAOYSA-N 4-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=C(S(Cl)(=O)=O)C=C1 JXRGUPLJCCDGKG-UHFFFAOYSA-N 0.000 description 1
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 1
- QZLYKIGBANMMBK-DYKIIFRCSA-N 5β-androstane Chemical group C([C@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CCC[C@@]2(C)CC1 QZLYKIGBANMMBK-DYKIIFRCSA-N 0.000 description 1
- JWMFYGXQPXQEEM-NUNROCCHSA-N 5β-pregnane Chemical compound C([C@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](CC)[C@@]2(C)CC1 JWMFYGXQPXQEEM-NUNROCCHSA-N 0.000 description 1
- YRHBFXZMYZMWFO-UHFFFAOYSA-N 9,10-dioxoanthracene-1-sulfonyl chloride Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2S(=O)(=O)Cl YRHBFXZMYZMWFO-UHFFFAOYSA-N 0.000 description 1
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 1
- 229910004373 HOAc Inorganic materials 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- HMNQNULAYXDEEQ-UHFFFAOYSA-N acetic acid;hydroxylamine Chemical compound ON.CC(O)=O HMNQNULAYXDEEQ-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001440 androstane derivatives Chemical class 0.000 description 1
- 229940061641 androsterone Drugs 0.000 description 1
- VMPVEPPRYRXYNP-UHFFFAOYSA-I antimony(5+);pentachloride Chemical compound Cl[Sb](Cl)(Cl)(Cl)Cl VMPVEPPRYRXYNP-UHFFFAOYSA-I 0.000 description 1
- 150000005840 aryl radicals Chemical class 0.000 description 1
- CGWWQPZGKPHLBU-UHFFFAOYSA-N benzenesulfonyl bromide Chemical compound BrS(=O)(=O)C1=CC=CC=C1 CGWWQPZGKPHLBU-UHFFFAOYSA-N 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000003951 lactams Chemical group 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- NCMZQTLCXHGLOK-ZKHIMWLXSA-N prasterone acetate Chemical compound C([C@@H]12)C[C@]3(C)C(=O)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)C)C1 NCMZQTLCXHGLOK-ZKHIMWLXSA-N 0.000 description 1
- 229950005326 prasterone acetate Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003126 pregnane derivatives Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003461 sulfonyl halides Chemical class 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Definitions
- This skeleton is known as the androstane skeleton or sometimes as the etio-cholane skeleton.
- androstane and pregnane'as used in this specification and in the appended claims are to be understood as comprehending steroids of 19 and 21 carbon atoms respectively, regardless of the particular stereo-chemical configuration in the nucleus.
- the term androstane compound is to be understood to include compounds having the alloconfiguration at C5 such as androsterone, or steroids having the regular configuration at C5 such as etio-cholanol-3(p) -one-17, as well as ring-unsaturated steroids such as testosterone.
- This method consists in converting a steroidal sapogenin into the corresponding pseudosapogenin and oxidizing the lat ter to a.
- a -unsaturated-20-keto-pregnane compound This sequence of transformations is 11. lustrated below, where only the essential changes in the molecule, which occur in ring D, are
- an object of this invention is to provide a practical method for preparing androstane compounds from pregnane compounds.
- a very satisfactory procedure for preparing a 1'7 keto-steroid comprises oximating a A -unsaturated20-keto-steroid, subjecting the resulting oxime to Beckmann rearrangement and hydrolizing the rearrangement product.
- the first step comprising the oximation of the A -unsaturated-2O-keto-steroid, can be accompli shed by reacting the ketone with hydroxyl tained is then hydrolyzed, e. g., by treatment with a diluted strong acid. It is unnecessary to isolate the Beckmann rearrangement product, instead it is sufficient to hydrolyze the crude reaction mixture.
- R and R are alkyl or aryl radicals or the like.
- the amides thus obtained are usually relatively resistant to hydrolysis, but when hydrolyzed, yield amines of the formula RNI-Iz.
- our new process does not require the use of strong oxidizing agents, and accordingly, pregnane derivatives unsaturated at other positions in the ring system in addition to at A may be degraded to the corresponding nuclearly unsaturated androstane derivatives with out protection of double bonds.
- our process provides a simple practical process for 012-- taining nuclearly unsaturated androstane compounds in high yields.
- the oximes of A -unsaturated-2O-keto-steroids formed as intermediates in our proces constitute a valuable class of steroidal hormone intermediates.
- a particularly useiul group of these oximes is representable by the formula:
- nY represents 11 substituents hydrolyzable to -OH in the rings-A-B portion of the steroid skeleton, n having one of the values 0, l and 2.
- mA represents m double bonds in the rings-A-B portiorrof the steroid skeleton, m having one of the values 0, 1 and'2, the sum n+m not exceeding the value 3.
- This class of substances includes: A -pregnadienone-20 oxime; A -pregnadienone-20 oxime; A -pregnadienol- 3( sl-one-20 acetate oxime; 3-chloro-A -pregnadienone-ZO oxime; A -allo-pregnenediol-3(e) 6-one-20 diacetate oxime; A -pregnendiol-3,6- one-20 diacetate oxime; A -pregnenediol-BA- one-20 dibenzoate oxime; and the like.
- R. is a group hydrolyzable to -OH, such as halogen, or acyloxy groups.
- R is a group hydrolyzable to -OH, such as halogen, or acyloxy groups.
- R is acylO
- the compounds where R is acylO are preferred because of their ease of preparation and conversion into intermediates suitable for the preparation of testosterone.
- Example 1 about two liters of water and the precipitate col ;"l'ected and washed with water.
- the crude prodnot thus obtained is recrystallized from methanol to give A -pregnenol-3( B) -one-20 acetate oxime of M. P. l97-205 C.- (dec.).
- sulfonyl halides such as benzenesulfonyl chloride, benzenesulfonyl bromide, methanesulfonyl chloride, anthraquinonesulfonyl chloride, p-nitrobenzenesulfonyl chloride, naphthalene-fl-sulfonyl chloride, and the like.
- pyridine instead of using pyridine, other tertiary amines may be used, such as dimethylaniline, tributylamine, N -ethylmorpholine, quinoline, or the like.
- a AIIo-pregnenone-Z A -Pregnadienone-20
- Example 2 (A) To a solution. of grams of A -pregnadienol-3(B) -oneacetate in 500 cc. of warm alcohol are added 15 grams of hydroxylamine hydrochloride in cc. of water and 22 grams of sodium acetate in 25 cc. of water. The mixture is allowed to stand at room temperature with occasional shakings for four days. The mixture is evaporated to a small volume in vacuo on a water bath at 40 C. and then diluted with two liters of water. The precipitated crude oxime is collected on a Buchner funnel, washed with water and dried. After crystallization from alcohol, it yields n -pregnadienol mp) -one-20 acetate oxime of M. P. 210215 C. (with decomposition).
- the ethereal extract is washed with dilute sulfuric acid, water, dilute sodium hydroxide, and again with water, and the ether is removed on a steam bath to leave a crystalline residue. This is recrystallized from dilute acetone to yield A -etio-cholenol-3(B) -one- 17 acetate of M. P. about 169 C.
- esters such as the propionate, butyrate, benzoate, naphththoate, palmitate, and the like.
- Example 3 To a, solution of 1 gram of A -pregnadienol- 3(;9)-one-20 acetate in 10 cc. pyridine are added 0.22 gram of hydroxylamine hydrochloride, and the mixture is allowed to stand at room temperature for four days. Then the mixture is cooled in an ice bath while 2.4 grams of benzenesulfonyl chloride are slowly added. After the mixture has stood for six hours, about 20 cc. of water are added dropwise with shaking to hydrolyze the reaction mixture. The hydrolysis is completed by pouring the mixture into a mixture of 20 cc. concentrated sulfuric acid, cc. of ice, and 100 cc. of ether. This mixture is shaken thoroughly and then allowed to stand overnight.
- Example 4 One gram of A -pregnadienol-3(fl)-one-20 acetate oxime is dissolved in 30 cc. of hot dioxan, and then the solution is cooled in an ice bath until about one-half of the dioxan has solidified. Then 1 g. of phosphorus pentachloride is added and the mixture is shaken until all the dioxan has melted. The mixture is maintained at 35 C. for seventy-five minutes, then an excess of ice is added and the solution is again allowed to stand at 35 C. After about thirty minutes, a solution of 5 cc. of concentrated hydrochloric acid in 10 cc.
- the isolation of the dehydroisonandrosterone is best accomplished as follows: The crude residue obtained above is refluxed for thirty minutes with 5 cc. of acetic anhydride. Then the excess acetic anhydride is removed in vacuo and the residue is crystallized from dilute methanol and finally from pure methanol to obtain dehydroisonandrosterone acetate of M. P. 165 C.
- the oximation of the A -unsaturated-20-ketosteroid may be accomplished by reacting the keto-steroid in alcohol solution with hydroxylamine acetate, free hydroxylamine or with the combination of a hydroxylamine acid addition salt and a dehydrohalogenating agent, such as sodium acetate, or a tertiary amine, such as pyridine.
- a dehydrohalogenating agent such as sodium acetate
- a tertiary amine such as pyridine.
- the Beckmann rearrangement of the A -unsaturated-steroidal-20-ketoxime may be accomplished by a host of different methods, such as are generally employed for effecting the Beckmann rearrangement. These methods are described, for example, in Houben, Die Methoden der organischen Chemie, second edition, volume 4, pages 356 if.
- the rearrangement may be effected by acidic agents or by agents which are reactive with water to form strong acids.
- Such reagents include hydrochloric acid, sulfuric acid, phosphorus pentachloride, thionyl chloride, antimony pentachloride, benzenesulfonyl chloride, benzoyl chloride and the like.
- a diluent such as acetic acid, dioxan, ether, benzene, or pyridine
- a diluent such as acetic acid, dioxan, ether, benzene, or pyridine
- R is a member of the class consisting 01 -OH and groups hydrolyzable to OH, which comprises oximating a steroid having the formula CH: CH: CH: 4 0
- R is a member of the class consisting of OH and groupshydrolyzable to OH, subjecting the resulting oxime to Beckmann rearrangement and hydrolyzing the rearrangement product.
- R is a member of the class consisting of -OH and groups hydrolyzable to OH, in a tertiary amine with a hydroxyl amine acid addition salt, reacting the resulting oxime with an 5 acid halide and hydrolyzing the rearrangement product with a diluted strong acid.
- R is a member of the class consisting of OH and groups hydrolyzable to OH, which comprises oximating a steroid having the formula CHICK:
- R. is a member 0! the class consisting of OH and groups hydrolyzable to OH, sub- Jecting the resulting oxime to Beckmann rearrangement and hydrolyzing the rearrangement product.
- R is a member of the class consisting of 0H and groups hydrolyzable to OH, in a tertiary amine with a hydroxyl amine acid addition salt, reacting the resulting oxime with an acid halide and hydrolyzing the rearrangement product with a diluted strong acid.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Description
Patented Nov. 30, 1943 I 2,335,616 STEROIDAL HORMONE UNITED STATES PATENT OFFICE INTERMEDIATES AND THEIR PREPARATION Frank H. Tcndick, Grosse Pointe Lawson, Detroit, Micln,
Park, and Elmer assiznors to Parke,
Davis & Company, Detroit, Micln, a corporation of Michigan No Drawing. Application November 6, 1941, Serial No. 418,076
14 Claims.
s I: J
This skeleton is known as the androstane skeleton or sometimes as the etio-cholane skeleton.
According to the present invention new improved methods are provided for passing to the androstane series from the pregnane series, the pregnane series being represented by the following skeleton:
on, CH:
The terms androstane and pregnane'as used in this specification and in the appended claims are to be understood as comprehending steroids of 19 and 21 carbon atoms respectively, regardless of the particular stereo-chemical configuration in the nucleus. For example, the term androstane compound is to be understood to include compounds having the alloconfiguration at C5 such as androsterone, or steroids having the regular configuration at C5 such as etio-cholanol-3(p) -one-17, as well as ring-unsaturated steroids such as testosterone.
In the past androstane compounds have been prepared by the degradation of the side chain of steroids or bile acids. However, these processes are extremely ineflicient and wasteful of material. Thus the yield of androstane compound from the oxidation of cholesterol is only of theorder of 1-2%. This low yield makes it necessary to process very large amounts of cholesterol in very large scale equipment in order to get useful amounts of the androstane compound.
Recently a method has been developed for the obtainment of pregnane compounds in high yields from the steroidal sapogenins [J. Am. Chem. Soc.
62, 3350 (1940)]. This method consists in converting a steroidal sapogenin into the corresponding pseudosapogenin and oxidizing the lat ter to a. A -unsaturated-20-keto-pregnane compound. This sequence of transformations is 11. lustrated below, where only the essential changes in the molecule, which occur in ring D, are
shown:
CH CH:
D o cn-om L CH|C a steroidalsapogenin 810.11), 101mm; alcohollcKOH CH: \CH! CH.
D C-CHpCHz-E-CHIOH o pseudosapogenin g OrOe-HOAc; hydrolysis CH: a.
s runsaturated-t o-keto-pregnane compound where A' represents 0 CH:& Because of these recent developments, A -unsaturated-20-keto-steroids, which have in ring D I the structure,
CH: CH:
are now available cheaply and in quantity; hence I stane compounds from pregnane compounds have been described in the past, these methods have proved to be impractical in commercial operation. Consequently, an object of this invention is to provide a practical method for preparing androstane compounds from pregnane compounds.
We have found that a very satisfactory procedure for preparing a 1'7 keto-steroid comprises oximating a A -unsaturated20-keto-steroid, subjecting the resulting oxime to Beckmann rearrangement and hydrolizing the rearrangement product.
The transformation involved may be represented as follows:
Bcckmann rearrangement and hydrolysis Here only the essential changes, occurring in ring D, have been shown.
The first step, comprising the oximation of the A -unsaturated-2O-keto-steroid, can be accompli shed by reacting the ketone with hydroxyl tained is then hydrolyzed, e. g., by treatment with a diluted strong acid. It is unnecessary to isolate the Beckmann rearrangement product, instead it is sufficient to hydrolyze the crude reaction mixture.
It will be noted that the above outlined process represents a novel application of the Beckmann rearrangement, for as ordinarily employed the Beckmann rearrangement transforms a ketoxime into a N-substituted amide as follows:
where R and R are alkyl or aryl radicals or the like. The amides thus obtained are usually relatively resistant to hydrolysis, but when hydrolyzed, yield amines of the formula RNI-Iz.
In contrast, our proces yields an intermediate which is readily hydrolyzed to yield a ll-ketosteroid.
It will also be noted that our new process does not require the use of strong oxidizing agents, and accordingly, pregnane derivatives unsaturated at other positions in the ring system in addition to at A may be degraded to the corresponding nuclearly unsaturated androstane derivatives with out protection of double bonds. Hence our process provides a simple practical process for 012-- taining nuclearly unsaturated androstane compounds in high yields.
The oximes of A -unsaturated-2O-keto-steroids formed as intermediates in our proces constitute a valuable class of steroidal hormone intermediates. A particularly useiul group of these oximes is representable by the formula:
where nY represents 11 substituents hydrolyzable to -OH in the rings-A-B portion of the steroid skeleton, n having one of the values 0, l and 2. and where mA represents m double bonds in the rings-A-B portiorrof the steroid skeleton, m having one of the values 0, 1 and'2, the sum n+m not exceeding the value 3. This class of substances includes: A -pregnadienone-20 oxime; A -pregnadienone-20 oxime; A -pregnadienol- 3( sl-one-20 acetate oxime; 3-chloro-A -pregnadienone-ZO oxime; A -allo-pregnenediol-3(e) 6-one-20 diacetate oxime; A -pregnendiol-3,6- one-20 diacetate oxime; A -pregnenediol-BA- one-20 dibenzoate oxime; and the like.
Certain subclasses of this group of new steroidal hormone intermediates have been found to be particularly useful. These have the forwhere R. is a group hydrolyzable to -OH, such as halogen, or acyloxy groups. Of these, the compounds where R is acylO are preferred because of their ease of preparation and conversion into intermediates suitable for the preparation of testosterone.
Our invention may be illustrated further by the following examples:
Example 1 about two liters of water and the precipitate col ;"l'ected and washed with water. The crude prodnot thus obtained is recrystallized from methanol to give A -pregnenol-3( B) -one-20 acetate oxime of M. P. l97-205 C.- (dec.).
(B) Five grams of the above oxime are dissolved in 25 cc. of dry pyridine, cooled in an ice bath, and 5 grams of p-toluene-sulfonyl chloride added. After one hour, the mixture is removed from the ice bath and allowed to stand at room temperature for four hours. Then the dark red solution is poured into an excess of aqueous sulfuric acid. The reaction flask is rinsed with alcohol and with ether, and the alcohol and ether washings added to the aqueous acidic mixture. After this mixture has stood overnight at room temperature, the hydrolysis is essentially complete. Then the mixture is extracted with ether and the ethereal extract washed thoroughly with dilute sulfuric acid, dilute sodium carbonate solution and water. The ether is removed on a steam bath and the residual solid crystallized from acetone containing a small amount of water. Thus there is obtained etio-cholanol-3(,B)- one-17 acetate of M. P. 157-158 C.
Instead of using p-toluenesulfonyl chloride in the above Beckmann rearrangement, other sulfonyl halides may be used, such as benzenesulfonyl chloride, benzenesulfonyl bromide, methanesulfonyl chloride, anthraquinonesulfonyl chloride, p-nitrobenzenesulfonyl chloride, naphthalene-fl-sulfonyl chloride, and the like. Likewise, instead of using pyridine, other tertiary amines may be used, such as dimethylaniline, tributylamine, N -ethylmorpholine, quinoline, or the like.
Again, instead of using A -pregneno1-3(fl)- one-20 acetate, other A -unsaturated-20-ketosteroids may be used. Thus the following transformations can be eflected, following the procedure outlined in the above example:
Starting material Final product A PrgnenoI-Nayone-ZO propiona A"- Allo pregnenol -3(fl) one -20 benzoate.
A"- Allo -pregnenol -3(a) -one-20 butyrata.
Etio ctlgolanol-3(a)-one-l7 propiona Etio-allo -cholanol-3(fl) -one -17 benzoate Etio -allo -cholanol 3(a) one 17 butyrate.
3-chloro-N-androstenone-H.
A -Androstenone-fl.
Androstanediol-3 (B) ,6-one-l7 diacetate Androsta none-17. A -Androstenone-l7.
A AIIo-pregnenone-Z) A -Pregnadienone-20 Example 2 (A) To a solution. of grams of A -pregnadienol-3(B) -oneacetate in 500 cc. of warm alcohol are added 15 grams of hydroxylamine hydrochloride in cc. of water and 22 grams of sodium acetate in 25 cc. of water. The mixture is allowed to stand at room temperature with occasional shakings for four days. The mixture is evaporated to a small volume in vacuo on a water bath at 40 C. and then diluted with two liters of water. The precipitated crude oxime is collected on a Buchner funnel, washed with water and dried. After crystallization from alcohol, it yields n -pregnadienol mp) -one-20 acetate oxime of M. P. 210215 C. (with decomposition).
(B) A solution of 6 grams of the above A pregnadienol-3QB) -one-20 acetate oxime in 30 cc. of dry pyridine is cooled in an ice bath while 6 grams of p-toluenesulfonyl chloride are added. After one hour, the mixture is removed from the ice bath and allowed to stand for four hours at room temperature. The reaction mixture is poured into an excess of dilute aqueous sulfuric acid, the material adhering to the sides of the reaction flask being transferred to the aqueous liquor with the aid of alcohol and ether. Then the hydrolyzing mixture is allowed to stand for three days at room temperature, after which it is extracted with ether. The ethereal extract is washed with dilute sulfuric acid, water, dilute sodium hydroxide, and again with water, and the ether is removed on a steam bath to leave a crystalline residue. This is recrystallized from dilute acetone to yield A -etio-cholenol-3(B) -one- 17 acetate of M. P. about 169 C.
Instead of using the acetate of A -pregnadienol-3(,6) -one-20 in the above example, there may be used other esters, such as the propionate, butyrate, benzoate, naphththoate, palmitate, and the like.
Example 3 To a, solution of 1 gram of A -pregnadienol- 3(;9)-one-20 acetate in 10 cc. pyridine are added 0.22 gram of hydroxylamine hydrochloride, and the mixture is allowed to stand at room temperature for four days. Then the mixture is cooled in an ice bath while 2.4 grams of benzenesulfonyl chloride are slowly added. After the mixture has stood for six hours, about 20 cc. of water are added dropwise with shaking to hydrolyze the reaction mixture. The hydrolysis is completed by pouring the mixture into a mixture of 20 cc. concentrated sulfuric acid, cc. of ice, and 100 cc. of ether. This mixture is shaken thoroughly and then allowed to stand overnight. The next morning the aqueous layer is discarded, and the ethereal layer is filtered from a small amount. of brown, insoluble impurity. The ethereal extract is washed with water, dilute sodium hydroxide and water, and evaporated to leave a residue which, after crystallization from methanol, gives A -etio-cholenol-3q3)-one-17 acetate of M. P. 169 C. This substance is frequently called dehydroisoandrosterone acetate.
Example 4 One gram of A -pregnadienol-3(fl)-one-20 acetate oxime is dissolved in 30 cc. of hot dioxan, and then the solution is cooled in an ice bath until about one-half of the dioxan has solidified. Then 1 g. of phosphorus pentachloride is added and the mixture is shaken until all the dioxan has melted. The mixture is maintained at 35 C. for seventy-five minutes, then an excess of ice is added and the solution is again allowed to stand at 35 C. After about thirty minutes, a solution of 5 cc. of concentrated hydrochloric acid in 10 cc. of water is added, and the mixture is diluted with water, extracted with ether and the ethereal extract washed with dilute sodium hydroxide solution. The etheris removed on a steam bath and the residue is worked up to yield dehydroisoandrosterone.
The isolation of the dehydroisonandrosterone is best accomplished as follows: The crude residue obtained above is refluxed for thirty minutes with 5 cc. of acetic anhydride. Then the excess acetic anhydride is removed in vacuo and the residue is crystallized from dilute methanol and finally from pure methanol to obtain dehydroisonandrosterone acetate of M. P. 165 C.
The yield by this procedure is considerably less than by the procedure of Example 3.
The above examples are subject to numerous variations with regard to the methods of conducting the reactions and isolating the products. Furthermore, the process is generally operable on A -unsaturated-steroidal-ZO-ketoximes, regardless of the structural features present in rings A, B, and C. However, it will be appreciated that transformations of these structural features in rings A, B, and C may occur during the process. For example, the application of our process to A -pregnenedione-3, 20 dioxime gives a 17- ketoandrostane derivative in which ring A has been transformed into a lactam ring. In genera1, it has been found that the presence in rings A, B, and C of acyloxy groups, halogens, and/or double bonds does not complicate the process, for these groups remain unaffected during the transformations of our process. On the other hand, ketone or hydroxyl groups are transformed in our process; so that steroids containing nuclear ketone groups, after oximation, rearrangement, and hydrolysis, yield ring-lactams; while nuclearly hydroxylated steroids are frequently esterified or dehydrated during the rearrangement process.
The oximation of the A -unsaturated-20-ketosteroid may be accomplished by reacting the keto-steroid in alcohol solution with hydroxylamine acetate, free hydroxylamine or with the combination of a hydroxylamine acid addition salt and a dehydrohalogenating agent, such as sodium acetate, or a tertiary amine, such as pyridine. In general, we have found it best to conduct the oximation under relatively mild conditions, so as to minimize the possibility of adding hydroxylamine to the A double bond.
The Beckmann rearrangement of the A -unsaturated-steroidal-20-ketoxime may be accomplished by a host of different methods, such as are generally employed for effecting the Beckmann rearrangement. These methods are described, for example, in Houben, Die Methoden der organischen Chemie, second edition, volume 4, pages 356 if. Thus the rearrangement may be effected by acidic agents or by agents which are reactive with water to form strong acids. Such reagents include hydrochloric acid, sulfuric acid, phosphorus pentachloride, thionyl chloride, antimony pentachloride, benzenesulfonyl chloride, benzoyl chloride and the like. The use of a diluent, such as acetic acid, dioxan, ether, benzene, or pyridine, is usually advisable to secure optimum yields. We have obtained especially satisfactory results by using diluents in which the oxime is reasonably soluble. Among such diluents, the most satisfactory appear to be tertiary amines. We prefer to use tertiary amines which contain no free hydroxyl groups or primary or secondary amino groups, i. e. tertiary amines which are not permanently attacked by acid halides. Tertiary amines containing hydroxyl groups, etc., may react at the hydroxyl groups, etc., with the acid halide; so the use of such substituted tertiary amines is often uneconomical.
We have obtained especially good results by the following simple procedure: The ri -unsaturated-20-keto-steroid in a tertiary amine, such as pyridine, is treated with a hydroxylamine acid addition salt, preferably the sulfate or the hydrochloride, thereby forming the oxime. Without isolating this oxime, it is rearranged in the tertiary amine diluent by adding an acid halide, preferably an aromatic sulfonyl chloride. After some standing, the reaction mixture is hydrolyzed by treatment with a diluted strong acid and the 17-keto-stero1d isolated and purified.
What we claim as our invention is:
l. The process for preparing a l'l-keto-steroid which comprises oximating a A -unsaturated- ZO-keto-steroid, subjecting the resulting oxime to Beckmann rearrangement and hydrolyzing the rearrangement product.
2. The process for preparing a steroid having in ring D the formula which comprises oximating a steroid having in ring D the structure which comprises reacting a steroid having the formula in a tertiary amine with a hydroxylamine acid addition salt, reacting the resulting oxime with an aromatic sulfonyl halide, and hydrolyzing the rearrangement product by treatment with a diluted strong acid.
4. The process for preparing a lower fatty acid ester of dehydroisoandrosterone, which comprises reacting a lower fatty acid ester of A pregnadienol-3 (,B)-one-20 in a tertiary amine with a hydroxylamine acid addition salt, reacting the resulting oxime with an aromatic sulfonyl halide and hydrolyzing the rearrangement product with a diluted strong acid.
5. A process according to claim 1 in which the oximation of the A -unsaturated-2fi-keto-steroid is accomplished by reacting said keto-steroid in a tertiary amine with a hydroxylamine acid addition salt.
6. A process according to claim 1 in which the Beckmann rearrangement is accomplished by treating the oxime in a tertiary amine with an acid halide.
7. A process according to claim 1 in which the Beckmann rearrangement is accomplished by reacting the oxime in a tertiary amine with an aromatic sulfonyl halide.
8. A process according to claim 1 in which the Beckmann rearrangement product is hydrolyzed by treatment with a diluted strong acid.
9. A process according to claim 1 in which the Beckmann rearrangement is accomplished by reacting the oxime in a tertiary amine with an aromatic sulfonyl chloride.
10. The process for preparinga l'l-keto-steroid which comprises subjecting a ri -unsaturatedsteroidal-ZO-ketoxime to Beckmann rearrangement and hydrolyzing the rearrangement product.
11. The process for preparing a steroid having the formula OH: OH:
where R is a member of the class consisting 01 -OH and groups hydrolyzable to OH, which comprises oximating a steroid having the formula CH: CH: CH: 4 0
n where R is a member of the class consisting of OH and groupshydrolyzable to OH, subjecting the resulting oxime to Beckmann rearrangement and hydrolyzing the rearrangement product.
12. The process for preparing a steroid having the formula where R is a member of the class consisting of OH and groups hydrolyzable to OH, which comprises reacting a steroid having the formula CH: CH:
where R is a member of the class consisting of -OH and groups hydrolyzable to OH, in a tertiary amine with a hydroxyl amine acid addition salt, reacting the resulting oxime with an 5 acid halide and hydrolyzing the rearrangement product with a diluted strong acid.
13. The process for preparing a steroid having the formula CH: CH;
where R is a member of the class consisting of OH and groups hydrolyzable to OH, which comprises oximating a steroid having the formula CHICK:
l Iii/ where R. is a member 0! the class consisting of OH and groups hydrolyzable to OH, sub- Jecting the resulting oxime to Beckmann rearrangement and hydrolyzing the rearrangement product.
preparing a steroid having CH: Jl=0 14. The process for the formula where R is a member of the class consisting of -OH and groups hydrolyzabie to OH, which comprises reacting a steroid having the formula OH; CH:
where R is a member of the class consisting of 0H and groups hydrolyzable to OH, in a tertiary amine with a hydroxyl amine acid addition salt, reacting the resulting oxime with an acid halide and hydrolyzing the rearrangement product with a diluted strong acid.
FRANK H. TENDICK. ELMER J. LAWSON.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US418076A US2335616A (en) | 1941-11-06 | 1941-11-06 | Steroidal hormone intermediates and their preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US418076A US2335616A (en) | 1941-11-06 | 1941-11-06 | Steroidal hormone intermediates and their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US2335616A true US2335616A (en) | 1943-11-30 |
Family
ID=23656608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US418076A Expired - Lifetime US2335616A (en) | 1941-11-06 | 1941-11-06 | Steroidal hormone intermediates and their preparation |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US2335616A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2657223A (en) * | 1948-10-11 | 1953-10-27 | Ciba Pharm Prod Inc | Process for the preparation of compounds with semicyclic double bond |
| DE1002351B (en) * | 1954-07-17 | 1957-02-14 | Lepetit Spa | Process for the production of 5-androsten-3 ª ‰ -ol-17-one-3-acetate (dehydroepiandrosterone acetate) |
| US2783252A (en) * | 1953-02-26 | 1957-02-26 | Hoechst Ag | Manufacture of 17-ketosteroids |
| US2929826A (en) * | 1957-02-25 | 1960-03-22 | Ciba Pharm Prod Inc | Process for preparation of 20-keto-16-pregnenes from 16-acyloxy-20-keto pregnanes |
| US2940967A (en) * | 1955-07-11 | 1960-06-14 | Synter S A | Process for the preparation of androsterone and intermediates therefor |
| US2971964A (en) * | 1958-03-04 | 1961-02-14 | Edward S Rothman | Preparation of 11alpha-hydroxy progesterone |
| US2998435A (en) * | 1958-01-10 | 1961-08-29 | British Drug Houses | 3beta-hydroxy and 3beta-acyloxy-6 methyl-androst-5-en-17-ones and process therefor |
| US3012046A (en) * | 1961-03-28 | 1961-12-05 | Upjohn Co | 3-mono and 20-mono-oximes of 11beta-hydroxy-5beta-pregnane-3, 20-dione and their corresponding 11alpha-methyl, 11alpha-allyl and 11alpha-methallyl derivatives |
| US3074979A (en) * | 1961-05-08 | 1963-01-22 | Merck & Co Inc | 3-mono-oxime derivatives of c-4 unsaturated steroids |
| EP1019060A4 (en) * | 1997-02-05 | 2005-04-13 | Univ Maryland | ANDROGENSYNTHESEINHIBITOREN |
-
1941
- 1941-11-06 US US418076A patent/US2335616A/en not_active Expired - Lifetime
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2657223A (en) * | 1948-10-11 | 1953-10-27 | Ciba Pharm Prod Inc | Process for the preparation of compounds with semicyclic double bond |
| US2783252A (en) * | 1953-02-26 | 1957-02-26 | Hoechst Ag | Manufacture of 17-ketosteroids |
| DE1002351B (en) * | 1954-07-17 | 1957-02-14 | Lepetit Spa | Process for the production of 5-androsten-3 ª ‰ -ol-17-one-3-acetate (dehydroepiandrosterone acetate) |
| DE1002351C2 (en) * | 1954-07-17 | 1957-07-18 | Lepetit Spa | Process for the production of 5-androsten-3 ª ‰ -ol-17-one-3-acetate (dehydroepiandrosterone acetate) |
| US2940967A (en) * | 1955-07-11 | 1960-06-14 | Synter S A | Process for the preparation of androsterone and intermediates therefor |
| US2929826A (en) * | 1957-02-25 | 1960-03-22 | Ciba Pharm Prod Inc | Process for preparation of 20-keto-16-pregnenes from 16-acyloxy-20-keto pregnanes |
| US2998435A (en) * | 1958-01-10 | 1961-08-29 | British Drug Houses | 3beta-hydroxy and 3beta-acyloxy-6 methyl-androst-5-en-17-ones and process therefor |
| US2971964A (en) * | 1958-03-04 | 1961-02-14 | Edward S Rothman | Preparation of 11alpha-hydroxy progesterone |
| US3012046A (en) * | 1961-03-28 | 1961-12-05 | Upjohn Co | 3-mono and 20-mono-oximes of 11beta-hydroxy-5beta-pregnane-3, 20-dione and their corresponding 11alpha-methyl, 11alpha-allyl and 11alpha-methallyl derivatives |
| US3074979A (en) * | 1961-05-08 | 1963-01-22 | Merck & Co Inc | 3-mono-oxime derivatives of c-4 unsaturated steroids |
| EP1019060A4 (en) * | 1997-02-05 | 2005-04-13 | Univ Maryland | ANDROGENSYNTHESEINHIBITOREN |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2335616A (en) | Steroidal hormone intermediates and their preparation | |
| US2735855A (en) | Process for producing a | |
| US2793218A (en) | 9alpha-halo-11-keto-17-alkyltestosterones | |
| DE3004508C2 (en) | Process for the preparation of 6-methylene steroids | |
| US2752366A (en) | Carbonyloxysteroids | |
| US2769824A (en) | Hydroxylation of delta-pregnenes | |
| DE1468410A1 (en) | Process for the preparation of 16-methylene steroids | |
| US2837517A (en) | 9, 11beta-epoxy-17-alkyltestosterones | |
| US2884417A (en) | 5, 6-dichloro pregnanes | |
| US3030391A (en) | 12-alkoxy-11-oxygenated pregnanes | |
| US2461563A (en) | Process for the degradation of the side-chain of steroids and steroids suitable therefor | |
| US2411172A (en) | 17-acetyl-17-hydroxy-perhydrocyclopentenophenanthrenes, anils, and oximes thereof, and method of preparing them | |
| US2533124A (en) | Preparation of steroid aldehydes | |
| US2783252A (en) | Manufacture of 17-ketosteroids | |
| US3043832A (en) | Preparation of 6alpha-methyl-17alpha-hydroxyprogesterone and 17alpha-esters thereof | |
| US2339281A (en) | Derivatives of sapogenins and their preparation | |
| US3160644A (en) | 1-dehydro-11-keto-9alpha-fluoro-17alpha-methyl testosterones | |
| US2752368A (en) | Oxidation of delta20(22)-22-tertiary amino steroids | |
| US2461910A (en) | Process for the degradation of the side-chain of steroids and steroids suitable therefor | |
| US2304100A (en) | Preparation of tertiary carbinols of the cyclopentanophenanthrene series | |
| DE1165595B (en) | Process for the preparation of triamcinolone acetonide-21-hemisuccinate and its salts | |
| US2311638A (en) | Halogenated compounds containing a sterol nucleus | |
| US2688624A (en) | Tribromosteroids | |
| US3066136A (en) | 16beta-(amino) carbonyl androstanes and process for the preparation thereof | |
| US2914544A (en) | Production of cyclopentanophenan-threne compounds |